- Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactisPieter Rottiers
ActoGeniX N V, Zwijnaarde, Belgium
Int Rev Immunol 28:465-86. 2009..The therapeutic applications of these genetically modified strains are discussed, with special regards to immunomodulation...
- AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositisSilvia Caluwaerts
ActoGeniX N V, Technologiepark 4, B 9052 Ghent Zwijnaarde, Belgium
Oral Oncol 46:564-70. 2010..lactis bacteria provides a safe and efficacious therapeutic tool for the prevention and treatment of OM...
- Actobiotics as a novel method for cytokine deliveryLothar Steidler
ActoGeniX NV, Zwijnaarde, Belgium
Ann N Y Acad Sci 1182:135-45. 2009..lactis- ActoBiotics- in clinical practice. Here we discuss the development of recombinant L. lactis for intestinal delivery of rhIL-10 in humans...